Ionis Pharmaceuticals (IONS) PT Raised to $125 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $62.04 +3.85%
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 7 | New: 77
Join SI Premium – FREE
H.C. Wainwright analyst Mitchell Kapoor raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $125.00 (from $120.00) while maintaining a Buy rating.
You May Also Be Interested In
- Canaccord Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
- BJ's Wholesale (BJ) PT Raised to $115 at UBS as Business Model 'Remains Relevant'
- XPeng (H-Shares) (9868:HK) (XPEV) PT Lowered to HK$71 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
